NOS1AP Polymorphisms Modify QTc Interval Duration But Not Cardiac Arrest Risk in Hypertrophic Cardiomyopathy

Journal of Cardiovascular Electrophysiology
N J EarleJonathan R Skinner

Abstract

The accurate prediction of the risk of sudden cardiac death (SCD) in hypertrophic cardiomyopathy (HCM) remains elusive. Corrected QT interval (QTc) duration is a known risk factor in various cardiac conditions. Single nucleotide polymorphisms (SNPs) have been linked to QTc length, and to SCD. Here we investigated the role of 21 candidate SNPs in QTc duration and SCD events in patients with HCM. This HCM registry-based study included patients with an ECG, medical history, first SCD event data, and DNA available. Each individual SNP was assessed using logistic regression for associations with 2 outcomes: a prolonged QTc ( ≥440 milliseconds), and first SCD event (SCD, resuscitated cardiac arrest, and appropriate implantable cardioverter defibrillator (ICD) shock for ventricular fibrillation/ventricular tachycardia (VF/VT). In 272 HCM patients, there were 31 SCD events (8 SCD, 9 resuscitated cardiac arrest, 14 ICD shocks for VF/VT; 11%). A QTc ≥ 500 milliseconds was associated with SCD events on multivariate analysis (odds ratio [OR] = 4.0, 95% confidence interval [CI], 1.19-12.02, P = 0.016). In 228 Caucasian patients, 2 SNPs in the NOS1AP gene (rs10494366 and rs12143842) were associated with a prolonged QTc after correction for m...Continue Reading

References

Jul 27, 2001·The American Journal of Cardiology·A M VarnavaW J McKenna
May 9, 2003·The New England Journal of Medicine·Silvia G PrioriDonata Cappelletti
Mar 25, 2005·American Journal of Human Genetics·Janis E WiggintonGoncalo R Abecasis
Dec 13, 2005·Journal of Internal Medicine·D M Roden
Feb 8, 2007·JAMA : the Journal of the American Medical Association·Nicholas L SmithBruce M Psaty
Jul 27, 2007·JAMA : the Journal of the American Medical Association·Barry J MaronPaolo Bruzzi
Jul 5, 2008·Heart Rhythm : the Official Journal of the Heart Rhythm Society·Pieter G PostemaArthur A M Wilde
Jan 27, 2009·Current Protocols in Human Genetics·Stacey GabrielDiana Tabbaa
Oct 8, 2013·Heart Rhythm : the Official Journal of the Heart Rhythm Society·Nikki EarleJonathan R Skinner
Oct 16, 2013·European Heart Journal·Constantinos O'MahonyUNKNOWN Hypertrophic Cardiomyopathy Outcomes Investigators
May 27, 2014·American Journal of Human Genetics·Ashish KapoorAravinda Chakravarti
Jul 7, 2014·Journal of the American College of Cardiology·Barry J MaronMartin S Maron

❮ Previous
Next ❯

Citations

Mar 15, 2018·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Hitesh ShuklaAbdullah Sabyah
Mar 30, 2021·Molecular Genetics and Metabolism Reports·Francesco CavaMaria Piane

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.